Alida Biosciences

New breakthrough in RNA research! Check out the latest bioRxiv & medRxiv preprint: "Mapping Multiple RNA Modifications Simultaneously by Proximity Barcode Sequencing." This study, developed by Sendinc et al. and the team of Richard I. Gregory, PhD, at Harvard Medical School—leaders in epitranscriptomics and molecular biology—demonstrates the simultaneous detection of multiple RNA modifications in a single run with a highly accurate and sensitive technique made possible by the Alida Biosciences EpiPlex™ RNA Library Prep. This breakthrough offers a powerful tool for advancing our understanding of RNA regulation, genomics, and disease mechanisms. Explore the findings here: https://lnkd.in/g23h33y3. #RNA #Genomics #Epitranscriptomics #Innovation #ScientificResearch #Biotech

Exciting news coming out of PMWC - Precision Medicine World Conference (#PMWC25)! GenomeWeb featured the commercial launch of our EpiPlex™ platform for multiplex #RNA modification analysis, sitting down with Alida Biosciences CEO Gudrun Stengel to learn how it will advance #epitranscriptomic research and its unique advantages, including low RNA input requirements ideal for clinically relevant samples. The article also highlights how the EpiPlex platform helped researchers at the Baylor College of Medicine Genomic and RNA Profiling Core with its rigorously validated, ready-to-go kits that overcome challenges with traditional immunoprecipitation-based methods using home-brew agents.  Learn more about this comprehensive, single-workflow solution and what’s ahead for AlidaBio here.  👉 https://lnkd.in/edB5Nfqm

At PMWC - Precision Medicine World Conference (#PMWC) this week? Don’t miss a chance to learn about #epitranscriptomics and its applications for finding new drug targets, therapeutics and basic and clinical research, and how innovative technology is making reading RNA modifications accessible to scientists of all skill levels across disciplines. Alida Biosciences CEO Gudrun Stengel will present “RNA Beyond Primary Sequence: Introducing Multiplexed Epitranscriptomics” and the new EpiPlexTM platform, which is transforming personalized medicine through RNA modification profiling. Stop by Hall C/D from 10:15 - 10:30 am PST during the Spatial/Multi-omics Solution Showcase or visit us at booth #D1142. #personalizedmedicine #precisionmedicine #genomics #multiomics #RNAseq #bioinformatics

Alida Biosciences is announcing an epic new chapter in  #epitranscriptomic research starting here at PMWC - Precision Medicine World Conference (#PMWC) with the launch of the EpiPlexTM platform! The EpiPlex platform is the first to simultaneously detect and quantify multiple #RNA modifications by short-read sequencing in addition to providing gene expression data. The platform is the first commercial solution to read the epitranscriptome that includes both a sensitive, robust assay and a user-friendly #bioinformatics package, making #epitranscriptomics broadly accessible to researchers of all skill levels. It offers: ☑ m6A and inosine detection in a single library prep ☑ High sensitivity and efficiency ideal for limited-input or degraded RNA samples ☑ One-click informatics solution  ☑ One-day workflow, not including sequencing time ☑ Collaboration-ready platform Interested in learning more about how to revolutionize RNA modification profiling to unlock new #biomarkers and therapeutic targets? Read more here: https://lnkd.in/egH3P7Ni join us at PMWC, or contact us at orders@alidabio.com.   #precisionmedicine #personalizedmedicine #genomics #multiomics #RNAseq #bioinformatics #RNAmodification

Alida Biosciences and CEO Gudrun Stengel will present at PMWC - Precision Medicine World Conference (#PMWC25) on Thursday next week! If you’re attending, join us to learn about how the EpiPlexTM platform is revolutionizing RNA modification profiling with high-throughput multi-target detection that is driving broader insights into the complex relationships between modifications and dynamic regulatory mechanisms in disease, aging and development. By revealing disease-specific #RNA modification patterns, EpiPlex is paving the way to transform #epitranscriptomics and #precisionmedicine.

Join AlidaBio at UCSD's Institute for Genomic Medicine to learn about how the EpiPlex Platform detects RNA modifications and enables new insights in human health and disease. Lunch provided! #epitranscriptome #RNAMods #m6A #inosine #NGS #UCSD #IGM #RNA #Biotech

Join our CEO, Gudrun Stengel at PAG 32 to learn about how the EpiPlex™ Platform can help you uncover new insights in plant, animal, and human health. #SanDiego #PAG32 #PAG2025 #Epitranscriptome #RNAmods #ScientificInnovation #LifeScienceCommunity

Join our VP of R&D, Andrew Price at the Association for Molecular Pathology (AMP) Corporate Workshop hosted by Thermo Fisher Scientific and featuring Alida Biosciences - "Epitranscriptomic Insights with EpiPlex™, the AlidaBio® Solution to Enhance Molecular Analysis". We are thrilled to share perspective on RNA modifications as powerful tools for human health with #ampath24. Hope to see you there! #amp24 #epitransctiptome #alidabio

We will present our latest poster about high sensitivity RNA modification detection in blood at the AACR Journals Special Conference in Cancer Research: Liquid Biopsy in San Diego. Please stop by the poster session and chat with Dr. Gudrun Stengel, CEO and co-founder of Alida Biosciences. #aacrLBx24 #epitranscriptomics #alidabio

While the weather in Denver is cold, RNA modifications are hot! We are having a blast meeting everyone at #ashg24, and hearing so much enthusiasm for the #epitranscriptome from the multiomic community. Please stop by booth #384 to meet the team! #ashg2024 #alidabio